Revision Hip Replacement Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Revision hip replacement is the replacement of the failed primary hip implants with a new implant. In revision hip replacement any of the damaged components (acetabular or femoral) of the hip joint are replaced. One unit refers to one implant set. GlobalData’s medical devices sector report provides comprehensive information about the revision of hip replacement devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

What are the market dynamics in the revision hip replacement devices pipeline products market?

As of November 2021, 5 pipeline products were in the approval process and 3 were in the inactive stage. Only one pipelined product was in the early development stage. During the same period, based on pipeline products by stage of development, 4 products from JRI Orthopaedics Ltd were in the approval process. Japan is the leading country in the market based on pipeline products by territory, followed by the US and Europe.

Which are the key players in the revision hip replacement devices pipeline products market?

Key players in the market are Corin Group Ltd, Exactech Inc, JRI Orthopaedics Ltd, Limacorporate SpA, MicroPort Orthopedics Inc, and Pro-Dex Inc. JRI Orthopaedics Ltd is the leading company in the market based on the pipeline products in the approval process, followed by Corin Group Ltd.

Company overview:

Corin Group Ltd. overview: Corin Group Ltd (Corin Group), a subsidiary of Corin Orthopaedics Holdings Ltd, carries out the development, production, and distribution of orthopedic devices. The group offers orthopedic devices for knees, hips, extremities, trauma, and ligaments. Corin Group markets its products under brands including Rotaglide+, Trinity, MiniHip, MetaFix, TaperFit, Uniglide, LARS, Zenith, and others. The group offers solutions to hip, knee, ankle, and soft tissue. It operates in the Americas, Europe, Asia Pacific, the Middle East, and Africa. Corin Group is headquartered in Gloucestershire, England, the UK.

Exactech Inc.: Exactech Inc (Exactech) is a medical device company that offers orthopedic implant devices and related surgical instruments. The company’s products comprise hip implants, shoulder implants, knee implants, extremity implants, biologics and spine, and other products. It also provides biologic services. Exactech’s hip products comprise neck preserving stem, tapered wedge stem, element stem, tapered and splined stems, and others. The company caters to hospitals, surgeons, and other physicians and clinics. It operates in France, the UK, Taiwan, Germany, Japan, and others. Exactech is headquartered in Gainesville, Florida, the US.

JRI Orthopaedics Ltd: JRI Orthopaedics Ltd (JRI) a subsidiary of Orthopaedic Research UK (ORUK), is a manufacturer of orthopedic implants and surgical instruments. The company develops products for joint replacement, repair, and reconstruction. It offers products for shoulder and knee arthroplasty, besides customized shoulder and hip products and a range of orthobiologics. Its product portfolio comprises tribofit hip system, trekking knee arthroplasty system, Furlong evolution, and securus revision system, among others. The company works in partnership with clinical and non-clinical academics, and other commercial collaborators for the development of novel materials, advanced manufacturing processes, and regenerative medical products. JRI is headquartered in Sheffield, the UK.

Limacorporate SpA: Limacorporate SpA (Lima), a subsidiary of EQT Partners AB, is a medical device company that develops, manufactures, and commercializes reconstructive and fixation orthopedic solutions. The company’s product portfolio includes large joint primary and revision implants, extremities and fixation devices, patient-specific prosthesis (Promade) products for surgeons worldwide. Lima harnesses its proprietary trabecular titanium technology for additive implants manufacturing to develop prosthetic components that resemble natural bone. It also provides additive implants and biomaterials such as trabecular titanium and bioceramics. The company focus on niche segments of the orthopaedics market, including extremities implants for the shoulder and elbow, implants manufactured for revision, and other complex surgeries. It has operations with R&D and production facilities in Italy and San Marino. Lima is headquartered in Udine, Italy.

MicroPort Orthopedics Inc: MicroPort Orthopedics Inc (MicroPort Orthopedics), a subsidiary of MicroPort Scientific Corp is a medical device company that specializes in designing, manufacturing, and marketing of reconstructive joint devices and related services. The company manufactures orthopedic devices for the hip system, limb salvage, and knee systems. Its products include tissue-sparing surgical approaches, acetabular hip systems, primary and revision total knee systems, and other personalized solutions. MicroPort Orthopedics serves products and services for doctors, patients, and hospitals. The company has its presence in China, the Netherlands, Germany, the UK, Japan, Canada, France, Brazil, and other countries. MicroPort Orthopedics is headquartered in Arlington, Tennessee, the US.

Pro-Dex Inc.: Pro-Dex Inc (Pro-Dex) is a medical device company that manufactures and markets surgical devices. The company’s products include motion control, finished medical devices, micro air motors, plastic injection molding, dental products, and torque wrenches. Its dental products comprise DLS handpiece system, oral surgery handpiece, and prophy plus. Pro-Dex offers services such as design and technical drafting, electronics and software, mechanical engineering and design, precision machining and assembly, quality and compliance, testing, prototyping and validation, and precision injection molding. It serves healthcare, aerospace, automotive, industrial, communications, dental, research, robotics, and oil and gas industries. Pro-Dex is headquartered in Irvine, California, the US.

Revision hip replacement devices pipeline products market, by key players

Revision hip replacement devices pipeline products market, by key players

To know more about key players, download a free report sample

Market report scope

Key countries/regions Japan, the US, and Europe
Key players Corin Group Ltd, Exactech Inc, JRI Orthopaedics Ltd, Limacorporate SpA, MicroPort Orthopedics Inc, and Pro-Dex Inc

 

Scope

  • Extensive coverage of the Revision Hip Replacement Devices under development.
  • The report reviews details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities.
  • The report reviews the major players involved in the development of Revision Hip Replacement Devices and lists all their pipeline projects.
  • The coverage of pipeline products is based on various stages of development ranging from Early Development to the Approved / Issued stage.
  • The report provides key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Revision Hip Replacement Devices under development.
  • Develop market entry and market expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Corin Group Ltd
Exactech Inc
JRI Orthopaedics Ltd
Limacorporate SpA
MicroPort Orthopedics Inc
Pro-Dex Inc

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 4

|1.2 List of Figures 5

2 Introduction 6

2.1 Revision Hip Replacement Overview 6

3 Products under Development 7

3.1 Revision Hip Replacement Devices – Pipeline Products by Stage of Development 7

3.2 Revision Hip Replacement Devices – Pipeline Products by Territory 8

3.3 Revision Hip Replacement Devices – Pipeline Products by Regulatory Path 9

3.4 Revision Hip Replacement Devices – Pipeline Products by Estimated Approval Date 10

4 Revision Hip Replacement Devices – Pipeline Products under Development by Companies 11

4.1 Revision Hip Replacement Companies – Pipeline Products by Stage of Development 11

4.2 Revision Hip Replacement Devices – Pipeline Products by Stage of Development 12

5 Revision Hip Replacement Companies and Product Overview 13

5.1 Corin Group Ltd Company Overview 13

5.1.1 Corin Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 13

5.2 Exactech Inc Company Overview 14

5.2.1 Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview 14

5.3 JRI Orthopaedics Ltd Company Overview 16

5.3.1 JRI Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview 16

5.4 Limacorporate SpA Company Overview 20

5.4.1 Limacorporate SpA Pipeline Products & Ongoing Clinical Trials Overview 20

5.5 MicroPort Orthopedics Inc Company Overview 21

5.5.1 MicroPort Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.6 Pro-Dex Inc Company Overview 22

5.6.1 Pro-Dex Inc Pipeline Products & Ongoing Clinical Trials Overview 22

6 Revision Hip Replacement- Recent Developments 23

6.1 Nov 18, 2021: Zimmer Biomet to Present at Evercore ISI’s 4th Annual HealthCONx Conference 23

6.2 Nov 03, 2021: Zimmer Biomet to Present at Stifel’s 2021 Virtual Healthcare Conference 23

6.3 Aug 03, 2021: Zimmer Biomet Announces Second Quarter 2021 Financial Results 23

6.4 Jul 29, 2021: Smith+Nephew Second Quarter and First Half 2021 Results 24

6.5 Jul 29, 2021: Smith & Nephew announces Half-year Report 25

6.6 Jul 07, 2021: Timing of Smith+Nephew Second Quarter Trading and First Half 2021 Results 26

6.7 Apr 06, 2021: Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2021 Financial Results 26

6.8 Mar 31, 2021: Zimmer Biomet Announces Key Updates to Company’s Executive Leadership Team 27

6.9 Mar 19, 2021: Zimmer Biomet expands role for Ivan Tornos appointing him to new COO 27

6.10 Mar 03, 2021: PrecisionOS to showcase collaboration with Zimmer Biomet 28

6.11 Feb 18, 2021: Zimmer Biomet to Present at the Cowen 41st Annual Health Care Conference 29

6.12 Feb 18, 2021: Smith+Nephew Fourth Quarter and Full Year 2020 Results 29

6.13 Feb 16, 2021: Vafa Jamali Appointed as CEO of “NewCo”, New Publicly Traded Spine and Dental Company to Spin Out of Zimmer Biomet 33

6.14 Feb 10, 2021: Zimmer Biomet to Present at Citi’s 2021 Healthcare Services, Medtech, Tools, and HCIT Virtual Conference 33

7 Appendix 34

7.1 Methodology 34

7.2 About GlobalData 37

7.3 Contact Us 37

Table

Revision Hip Replacement Devices – Pipeline Products by Stage of Development 7

Revision Hip Replacement Devices – Pipeline Products by Territory 8

Revision Hip Replacement Devices – Pipeline Products by Regulatory Path 9

Revision Hip Replacement Devices – Pipeline Products by Estimated Approval Date 10

Revision Hip Replacement Companies – Pipeline Products by Stage of Development 11

Revision Hip Replacement Devices – Pipeline Products by Stage of Development 12

Corin Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 13

Trinity Plus – Product Status 13

Trinity Plus – Product Description 13

Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview 14

Alteon Revision Modular System – Product Status 14

Alteon Revision Modular System – Product Description 14

Hip Revision System – Product Status 15

Hip Revision System – Product Description 15

JRI Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview 16

Furlong H-A.C. Revision Hip Stem – Product Status 16

Furlong H-A.C. Revision Hip Stem – Product Description 16

Furlong Securus Femoral Revision System – Product Status 17

Furlong Securus Femoral Revision System – Product Description 17

MRP-Titan – Product Status 17

MRP-Titan – Product Description 18

MRS Comfort Revision Cup – Product Status 18

MRS Comfort Revision Cup – Product Description 19

Limacorporate SpA Pipeline Products & Ongoing Clinical Trials Overview 20

DELTA-Revision TT – Product Status 20

DELTA-Revision TT – Product Description 20

MicroPort Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview 21

Classic Revision Stem – Product Status 21

Classic Revision Stem – Product Description 21

Pro-Dex Inc Pipeline Products & Ongoing Clinical Trials Overview 22

Acetabular Cup Revision Tool – Product Status 22

Acetabular Cup Revision Tool – Product Description 22

Figures

Revision Hip Replacement Devices – Pipeline Products by Stage of Development 7

Revision Hip Replacement Devices – Pipeline Products by Territory 8

Revision Hip Replacement Devices – Pipeline Products by Regulatory Path 9

Frequently asked questions

Revision Hip Replacement Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 standard reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Revision Hip Replacement Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Revision Hip Replacement Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 in real time.

  • Access a live Revision Hip Replacement Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.